Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1370402 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Abstract
Novel indole-3-thio-, 3-sulfonyl- and 3-oxy-aryl-1-acetic acids are reported which are potent, selective antagonists of the chemoattractant receptor-homologous expressed on Th2 lymphocytes receptor (CRTh2 or DP2). Optimization required maintenance of high CRTh2 potency whilst achieving a concomitant reduction in rates of metabolism, removal of cyp p450 inhibition and minimization of aldose reductase and aldehyde reductase activity. High quality compounds suitable for in vivo studies are highlighted, culminating in the discovery of AZD1981 (22).
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Tim Luker, Roger Bonnert, Steve Brough, Anthony R. Cook, Mark R. Dickinson, Iain Dougall, Chris Logan, Rukhsana T. Mohammed, Stuart Paine, Hitesh J. Sanganee, Carol Sargent, Jerzy A. Schmidt, Simon Teague, Stephen Thom,